Literature DB >> 21222105

Expression of matrix metalloproteinases 1, 3, and 9 in differing extents of tendon retraction in the torn rotator cuff.

Stefan Lakemeier1, Juliane Braun, Turgay Efe, Christian Foelsch, Eleni Archontidou-Aprin, Susanne Fuchs-Winkelmann, Juergen R J Paletta, Markus D Schofer.   

Abstract

PURPOSE: Differing extents of tendon retraction are found in full-thickness rotator cuff tears. The pathophysiologic context of tendon degeneration and the extent of tendon retraction are unclear. Tendon integrity depends on the extracellular matrix, which is regulated by matrix metalloproteinases (MMP). It is unknown which enzymes play a role in tendon degeneration. The hypotheses are that (1) the expression of MMPs 1, 3, and 9 is altered in the torn rotator cuff when compared with healthy tendon samples; and (2) that there is a relationship between MMP expression and the extent of tendon retraction in the torn cuff.
METHODS: Rotator cuff tendon samples of 33 patients with full-thickness rotator cuff tears (Bateman grade III) were harvested during reconstructive surgery. Samples were dehydrated and paraffin-embedded. Immunohistologic determination of MMP 1, 3, and 9 expression was performed by staining sample slices with MMP antibody. The extent of tendon retraction was determined intraoperatively according to Patte's classification and patients were assigned to 4 groups (control group, and by tendon retraction grade Patte I-III). The control group consisted of six healthy tendon samples.
RESULTS: Expression of MMPs 1 and 9 was significantly higher in torn cuff samples than in healthy tendons whereas MMP 3 expression was significantly decreased (P < 0.05). MMP 9 expression significantly increased with rising extent of tendon retraction in the torn cuff (P < 0.05). No significant association was found between expression of MMPs 1 and 3 and the rising extent of tendon retraction by Patte's classification.
CONCLUSION: Elevated expression of MMPs 1 and 9 as well as decreased MMP 3 expression can be detected in torn rotator cuff tendon tissue. There is a significant association between the extent of tendon retraction and MMP 9 expression. The results of this study give evidence that early surgical treatment of small and partial-thickness rotator cuff tears is required.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21222105     DOI: 10.1007/s00167-010-1367-y

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  43 in total

Review 1.  The pathogenesis of tendinopathy. A molecular perspective.

Authors:  G Riley
Journal:  Rheumatology (Oxford)       Date:  2003-07-16       Impact factor: 7.580

2.  Genetic influences in the progression of tears of the rotator cuff.

Authors:  S E Gwilym; B Watkins; C D Cooper; P Harvie; S Auplish; T C B Pollard; J L Rees; A J Carr
Journal:  J Bone Joint Surg Br       Date:  2009-07

3.  Correlations between biochemical markers in the synovial fluid and severity of rotator cuff disease.

Authors:  M S Tajana; L Murena; F Valli; A Passi; F A Grassi
Journal:  Chir Organi Mov       Date:  2009-04

4.  Classification of rotator cuff lesions.

Authors:  D Patte
Journal:  Clin Orthop Relat Res       Date:  1990-05       Impact factor: 4.176

5.  Anterior acromioplasty for the chronic impingement syndrome in the shoulder: a preliminary report.

Authors:  C S Neer
Journal:  J Bone Joint Surg Am       Date:  1972-01       Impact factor: 5.284

6.  [Biochemical analysis of the synovial fluid of the shoulder joint in patients with and without rotator cuff tears].

Authors:  L J Lehmann; A Schollmeyer; J Stoeve; H-P Scharf
Journal:  Z Orthop Unfall       Date:  2009-10-19       Impact factor: 0.923

7.  Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase mRNA levels are specifically altered in torn rotator cuff tendons.

Authors:  Ian K Y Lo; Linda L Marchuk; Robert Hollinshead; David A Hart; Cyril B Frank
Journal:  Am J Sports Med       Date:  2004-05-18       Impact factor: 6.202

8.  Increased expression of matrix metalloproteinase 1 (MMP1) in 11 patients with patellar tendinosis.

Authors:  Sai C Fu; Barbara P Chan; Wen Wang; Hon M Pau; Kai M Chan; Christer G Rolf
Journal:  Acta Orthop Scand       Date:  2002-12

9.  Doxycycline-mediated inhibition of matrix metalloproteinases improves healing after rotator cuff repair.

Authors:  Asheesh Bedi; Alice J S Fox; David Kovacevic; Xeng-Hua Deng; Russell F Warren; Scott A Rodeo
Journal:  Am J Sports Med       Date:  2009-10-13       Impact factor: 6.202

10.  Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon.

Authors:  Gavin C Jones; Anthony N Corps; Caroline J Pennington; Ian M Clark; Dylan R Edwards; Michelle M Bradley; Brian L Hazleman; Graham P Riley
Journal:  Arthritis Rheum       Date:  2006-03
View more
  20 in total

1.  Inhibition of CD44 induces apoptosis, inflammation, and matrix metalloproteinase expression in tendinopathy.

Authors:  Po-Ting Wu; Wei-Ren Su; Chia-Lung Li; Jeng-Long Hsieh; Ching-Hou Ma; Chao-Liang Wu; Li-Chieh Kuo; I-Ming Jou; Shih-Yao Chen
Journal:  J Biol Chem       Date:  2019-11-15       Impact factor: 5.157

2.  Matrix Metalloproteases 1 and 3 Promoter Gene Polymorphism Is Associated With Rotator Cuff Tear.

Authors:  Jorge H Assunção; Alexandre L Godoy-Santos; Maria Cristina L G Dos Santos; Eduardo A Malavolta; Mauro E C Gracitelli; Arnaldo A Ferreira Neto
Journal:  Clin Orthop Relat Res       Date:  2017-02-03       Impact factor: 4.176

3.  Increased matrix metalloprotease-3 gene expression in ruptured rotator cuff tendons is associated with postoperative tendon retear.

Authors:  Masafumi Gotoh; Yasuhiro Mitsui; Hideaki Shibata; Tetsu Yamada; Isao Shirachi; Kenjiro Nakama; Takahiro Okawa; Fujio Higuchi; Kensei Nagata
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-09-22       Impact factor: 4.342

4.  Metalloproteases and their inhibitors are altered in both torn and intact rotator cuff tendons.

Authors:  A Castagna; E Cesari; A Gigante; M Conti; R Garofalo
Journal:  Musculoskelet Surg       Date:  2013-04-21

5.  Effect of interleukin-1β and tumor necrosis factor α gene silencing on mouse gastric cancer cell proliferation and migration.

Authors:  Zhongwei Sun; Yan Meng; Guoqin Liu; Yongsheng Jiang; Qinghua Meng; Sanyuan Hu
Journal:  Oncol Lett       Date:  2016-02-19       Impact factor: 2.967

6.  Changes in matrix protein biochemistry and the expression of mRNA encoding matrix proteins and metalloproteinases in posterior tibialis tendinopathy.

Authors:  Anthony N Corps; Andrew H N Robinson; Rebecca L Harrall; Nicholas C Avery; Valerie A Curry; Brian L Hazleman; Graham P Riley
Journal:  Ann Rheum Dis       Date:  2012-01-12       Impact factor: 19.103

7.  Do Matrix Metalloproteases and Tissue Inhibitors of Metalloproteases in Tenocytes of the Rotator Cuff Differ with Varying Donor Characteristics?

Authors:  Franka Klatte-Schulz; Thomas Aleyt; Stephan Pauly; Sven Geißler; Christian Gerhardt; Markus Scheibel; Britt Wildemann
Journal:  Int J Mol Sci       Date:  2015-06-09       Impact factor: 5.923

Review 8.  Proteomics perspectives in rotator cuff research: a systematic review of gene expression and protein composition in human tendinopathy.

Authors:  Maria Hee Jung Sejersen; Poul Frost; Torben Bæk Hansen; Søren Rasmussen Deutch; Susanne Wulff Svendsen
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

9.  Differences in glutamate receptors and inflammatory cell numbers are associated with the resolution of pain in human rotator cuff tendinopathy.

Authors:  Benjamin John Floyd Dean; Sarah J B Snelling; Stephanie G Dakin; Richard J Murphy; Muhammad Kassim Javaid; Andrew Jonathan Carr
Journal:  Arthritis Res Ther       Date:  2015-07-10       Impact factor: 5.156

10.  A systematic review of the histological and molecular changes in rotator cuff disease.

Authors:  B J F Dean; S L Franklin; A J Carr
Journal:  Bone Joint Res       Date:  2012-07-01       Impact factor: 5.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.